eHealth Stock Forecast, Price & News

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for eHealth in the last twelve months. There are currently 3 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" eHealth stock.
View analyst ratings for eHealth or view top-rated stocks.

Wall Street analysts have given eHealth a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but eHealth wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

eHealth is scheduled to release its next quarterly earnings announcement on Thursday, April 22nd 2021.
View our earnings forecast for eHealth.

eHealth, Inc. (NASDAQ:EHTH) posted its quarterly earnings results on Wednesday, February, 17th. The financial services provider reported $2.32 earnings per share for the quarter, topping the Zacks' consensus estimate of $2.06 by $0.26. eHealth had a net margin of 12.59% and a trailing twelve-month return on equity of 11.13%.
View eHealth's earnings history.

eHealth's stock was trading at $127.09 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, EHTH stock has decreased by 58.3% and is now trading at $53.00.
View which stocks have been most impacted by COVID-19.

eHealth updated its FY 2021 After-Hours earnings guidance on Thursday, February, 18th. The company provided earnings per share guidance of 2.77-3.26 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.92. The company issued revenue guidance of $660-700 million, compared to the consensus revenue estimate of $760.62 million.

12 analysts have issued 12 month price objectives for eHealth's shares. Their forecasts range from $63.00 to $200.00. On average, they anticipate eHealth's stock price to reach $118.69 in the next twelve months. This suggests a possible upside of 123.9% from the stock's current price.
View analysts' price targets for eHealth or view top-rated stocks among Wall Street analysts.

60 employees have rated eHealth CEO Scott Flanders on Glassdoor.com. Scott Flanders has an approval rating of 67% among eHealth's employees.

Some companies that are related to eHealth include Goosehead Insurance (GSHD), Ashmore Group (AJMPF), SelectQuote (SLQT), GoHealth (GOCO), CorVel (CRVL), BRP Group (BRP), Fanhua (FANH), Huize (HUIZ), AA (AATDF), The Marketing Alliance (MAAL), Arista Investors (ARINA), Patriot National (PNTPQ) and UMC (UMCN).
View all of EHTH's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other eHealth investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Advanced Micro Devices (AMD), AbbVie (ABBV), Tesla (TSLA), Netflix (NFLX), salesforce.com (CRM), DocuSign (DOCU) and JPMorgan Chase & Co. (JPM).

eHealth trades on the NASDAQ under the ticker symbol "EHTH."

eHealth's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.40%), Ruffer LLP (5.59%), Orbimed Advisors LLC (3.26%), Villere ST Denis J & Co. LLC (3.25%), Dimensional Fund Advisors LP (2.41%) and Credit Suisse AG (2.23%). Company insiders that own eHealth stock include Beth A Brooke, Dale B Wolf, David K Francis, Derek N Yung, Ian Jay Kalin, Jack L Oliver III, Michael Goldberg, Phillip A Morelock, Randall S Livingston, Robert S Hurley, Scott N Flanders and Timothy C Hannan.
View institutional ownership trends for eHealth.

EHTH stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Morgan Stanley, Handelsbanken Fonder AB, Emerald Advisers LLC, The Manufacturers Life Insurance Company , Ashfield Capital Partners LLC, Dimensional Fund Advisors LP, and Northern Trust Corp. Company insiders that have sold eHealth company stock in the last year include David K Francis, Derek N Yung, Jack L Oliver III, Michael Goldberg, and Timothy C Hannan.
View insider buying and selling activity for eHealth or view top insider-selling stocks.

EHTH stock was bought by a variety of institutional investors in the last quarter, including Ruffer LLP, Norges Bank, Orbimed Advisors LLC, Jennison Associates LLC, Epoch Investment Partners Inc., Price T Rowe Associates Inc. MD, Credit Suisse AG, and Kornitzer Capital Management Inc. KS. Company insiders that have bought eHealth stock in the last two years include Beth A Brooke, Dale B Wolf, Phillip A Morelock, and Scott N Flanders.
View insider buying and selling activity for eHealth or or view top insider-buying stocks.

Shares of EHTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EHTH stock can currently be purchased for approximately $53.00.

eHealth has a market capitalization of $1.37 billion and generates $506.20 million in revenue each year. The financial services provider earns $66.89 million in net income (profit) each year or $3.50 on an earnings per share basis.

eHealth employs 1,500 workers across the globe.

The official website for eHealth is www.ehealthinsurance.com.

eHealth is headquartered at 2625 AUGUSTINE DRIVE SECOND FLOOR, SANTA CLARA CA, 95054.

eHealth's mailing address is 2625 AUGUSTINE DRIVE SECOND FLOOR, SANTA CLARA CA, 95054. The financial services provider can be reached via phone at 650-584-2700 or via email at [email protected]